← Leaderboards
Matthew Roger Leblanc
Duke University
$66,370
Attributed
$66,370
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.6K · FY2019–20$50K$37.5K$25K$12.5K$0
'19
'20
Funding mix
By agency
NIH$66,370 · 1
By mechanism
F31$66,370 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Kathryn Whetten$19,488,520
- Anthony G Visco$7,618,783
- Susan Davis Emmett$5,103,176
- Kenneth A Dodge$42,207,577
- Robert L. Hubbard$16,470,419
Others in their field
Other Emerging Leaders on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Kimberly Smith · Ppd Development Lp$116,656,661
- Klaus Romero · Critical Path Institute$88,602,036
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$59,913,818
Research focus
Advanced DiseaseAffectAfrican AmericanAging PopulationAmericanAnemiaAnxietyBaseBoneCancer DiagnosisCancer PatientCareerCaringCessation Of LifeCharacteristicsChronicClinical PracticeCohortCohort StudiesCollaborationsComorbidityComplexCoupledAcute